New York State Teachers Retirement System raised its holdings in Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 4.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 75,215 shares of the company’s stock after acquiring an additional 2,921 shares during the quarter. New York State Teachers Retirement System owned 0.16% of Avanos Medical worth $1,197,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently bought and sold shares of AVNS. FMR LLC lifted its stake in Avanos Medical by 34.6% during the third quarter. FMR LLC now owns 133,844 shares of the company’s stock valued at $3,216,000 after buying an additional 34,421 shares in the last quarter. Barclays PLC lifted its stake in Avanos Medical by 446.2% during the third quarter. Barclays PLC now owns 96,194 shares of the company’s stock valued at $2,311,000 after buying an additional 78,583 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Avanos Medical by 12.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 108,470 shares of the company’s stock worth $2,607,000 after purchasing an additional 11,613 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Avanos Medical by 6.9% in the third quarter. JPMorgan Chase & Co. now owns 69,571 shares of the company’s stock worth $1,672,000 after purchasing an additional 4,472 shares in the last quarter. Finally, Jane Street Group LLC lifted its position in shares of Avanos Medical by 35.8% in the third quarter. Jane Street Group LLC now owns 65,650 shares of the company’s stock worth $1,578,000 after purchasing an additional 17,306 shares in the last quarter. 95.17% of the stock is owned by institutional investors and hedge funds.
Avanos Medical Trading Up 0.0 %
Shares of AVNS stock opened at $15.49 on Monday. Avanos Medical, Inc. has a 12 month low of $14.98 and a 12 month high of $25.36. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The business’s 50 day moving average is $16.22 and its two-hundred day moving average is $19.83. The company has a market cap of $711.78 million, a PE ratio of 45.55 and a beta of 0.98.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on Avanos Medical
Avanos Medical Company Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
- Five stocks we like better than Avanos Medical
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- How to Capture the Benefits of Dividend Increases
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- With Risk Tolerance, One Size Does Not Fit All
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Free Report).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.